Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Susan Domchek

Showing results (11-20 of 94) with videos related to

Pageof 10
Sort By:
Journal of the National Cancer Institute|August 13, 2015
RE: Breast Cancer Risk After Salpingo-Oophorectomy in Healthy BRCA1/2 Mutation Carriers: Revisiting the Evidence for Risk ReductionXinglei Chai, Susan Domchek, Noah Kauff, et al.
JNCI Cancer Spectrum|March 18, 2021
Clinical Characteristics of Patients With Pancreatic Cancer and Pathogenic <i>ATM</i> AlterationsZain Hannan, Shun Yu, Susan Domchek, et al.
Archives of Internal Medicine|March 16, 2005
Patients' resistance to risk information in genetic counseling for BRCA1/2Andrea D Gurmankin, Susan Domchek, Jill Stopfer, et al.
Archives of Internal Medicine|November 15, 2006
Prescription of tamoxifen for breast cancer prevention by primary care physiciansKatrina Armstrong, D Alex Quistberg, Ellyn Micco, et al.
Patient Education and Counseling|March 15, 2006
Satisfaction with genetic counseling for BRCA1 and BRCA2 mutations among African American womenSarah Charles, Lisa Kessler, Jill E Stopfer, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|September 19, 2006
Low rates of acceptance of BRCA1 and BRCA2 test results among African American women at increased risk for hereditary breast-ovarian cancerChanita Hughes Halbert, Lisa Kessler, Jill E Stopfer, et al.
Fertility and Sterility|May 7, 2017
Antimüllerian hormone levels are lower in BRCA2 mutation carriersLauren Johnson, Mary D Sammel, Susan Domchek, et al.
Pathology|July 1, 2022
The increasing importance of pathology in modern clinical trial conduct: OlympiA as a case in pointLauren Kalinowski, Giuseppe Viale, Susan Domchek, et al.
Family & Community Health|June 16, 2009
Utilization of religious coping strategies among African American women at increased risk for hereditary breast and ovarian cancerBenita Weathers, Lisa Kessler, Aliya Collier, et al.
The Canadian Journal of Urology|October 21, 2019
Genetic counseling and oncology: proposed approaches for collaborative care deliveryJacquelyn Powers, Kelsey Spielman, Rebecca Mueller, et al.
Pageof 10

Showing results (11-20 of 94) with videos related to

Sort By:
Pageof 10
Journal of the National Cancer Institute|August 13, 2015
RE: Breast Cancer Risk After Salpingo-Oophorectomy in Healthy BRCA1/2 Mutation Carriers: Revisiting the Evidence for Risk ReductionXinglei Chai, Susan Domchek, Noah Kauff, et al.
JNCI Cancer Spectrum|March 18, 2021
Clinical Characteristics of Patients With Pancreatic Cancer and Pathogenic <i>ATM</i> AlterationsZain Hannan, Shun Yu, Susan Domchek, et al.
Archives of Internal Medicine|March 16, 2005
Patients' resistance to risk information in genetic counseling for BRCA1/2Andrea D Gurmankin, Susan Domchek, Jill Stopfer, et al.
Archives of Internal Medicine|November 15, 2006
Prescription of tamoxifen for breast cancer prevention by primary care physiciansKatrina Armstrong, D Alex Quistberg, Ellyn Micco, et al.
Patient Education and Counseling|March 15, 2006
Satisfaction with genetic counseling for BRCA1 and BRCA2 mutations among African American womenSarah Charles, Lisa Kessler, Jill E Stopfer, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|September 19, 2006
Low rates of acceptance of BRCA1 and BRCA2 test results among African American women at increased risk for hereditary breast-ovarian cancerChanita Hughes Halbert, Lisa Kessler, Jill E Stopfer, et al.
Fertility and Sterility|May 7, 2017
Antimüllerian hormone levels are lower in BRCA2 mutation carriersLauren Johnson, Mary D Sammel, Susan Domchek, et al.
Pathology|July 1, 2022
The increasing importance of pathology in modern clinical trial conduct: OlympiA as a case in pointLauren Kalinowski, Giuseppe Viale, Susan Domchek, et al.
Family & Community Health|June 16, 2009
Utilization of religious coping strategies among African American women at increased risk for hereditary breast and ovarian cancerBenita Weathers, Lisa Kessler, Aliya Collier, et al.
The Canadian Journal of Urology|October 21, 2019
Genetic counseling and oncology: proposed approaches for collaborative care deliveryJacquelyn Powers, Kelsey Spielman, Rebecca Mueller, et al.
Pageof 10